1[1]Jabs WJ, Logering BA, Gerke P, et al. Kidney as a second site of human C-reactive protein formation in vivo. Eur J immunology, 2003, 33 152～161.
2[2]Woo P, Korenberg JR, Whitehead AS, et al. Characterizaton of genomic and complementary DNA sequence of human C-reactive protein,and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem,1989,260 13384～13388
3[3]Shrive AK, Gheetham GM,Holden D, et al. Three dimention structure of C-reactive protein. Nature Struc Biol,1996,3 346～354.
4[4]Angrawal A, Lee S, Carson M, et al. Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein. J Immunol,1997,166 3998～4004.
5[5]Bharadwaj D,Stein MP,Volzer M, et al. The major receptor for C-reactive protein on leukorcyte is FcgRII .J Exp Med,1999,190 585～590
7[7]Liuzzo G,Biasucci LM,Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med, 1994,331 417～424.
8[8]Biasucci LM,Liuzzo G,Grillo RL, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predicts recurrent instability.Circulation,1999,99 855～860.
9[9]Gaspardone A,Grea F,Versaci F, et al. Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina. Am J Cardiol,1998,82 515～518.
10[10]Ridker PM,Cushman M,Stampfer MJ, et al. Inflammation,aspirin,and the risk of cardiovascular disease in apparently healthy men. N Engl J Med,1997,336 973～979.
4Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary aherosclerosis:A Randomized controlled trial[J].JAMA,2004,291:1071-1080.
5Heart Protection Study Collaborative Group.MRC/BHF Heart Protection study of cholesterol lowering with simvastatin in 20,536 highrisk individuals:A randomizedplacebo-controlled trial[J].Lancet,2002,360(9326):7.
6Biasucci LM,Liuzzo G,Grillo RL,et al.Elevated levels of C-reactive proteinat discharge in patient with unstable angina pectoris recurrent instability[J].Circulation,1999,99:2079-2084.
7Karaca I,Hkay E,Akbulut M,et al.Atorvastatia affects C-reactive protein levels in patients with coronary artery disease[J].Curr Med Res Opin,2003,19(3):187.
